Jaguar Health, Inc.
JAGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001585608
No open-market purchases or sales by Jaguar Health, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $15.9K in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Jaguar Health, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- −8 vs. Q1 2024
- Shares held
- 102.5K
- −5.72M (−98.2%) vs. Q1 2024
- Total value
- $367.0K
- −$156.8K (−29.9%) vs. Q1 2024
- New holders
- 4
- 0 more added
- Sold out
- 12
- 8 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JAGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $15.9K |
| Q1 2026 | 11 | $94.2K |
| Q4 2025 | 11 | $61.4K |
| Q3 2025 | 9 | $222.9K |
| Q2 2025 | 8 | $35.2K |
| Q1 2025 | 8 | $24.6K |
| Q4 2024 | 12 | $283.4K |
| Q3 2024 | 13 | $387.1K |
| Q2 2024 | 12 | $367.0K |
| Q1 2024 | 20 | $523.7K |
| Q4 2023 | 20 | $184.4K |
| Q3 2023 | 14 | $153.2K |
| Q2 2023 | 16 | $231.3K |
| Q1 2023 | 16 | $229.0K |
| Q4 2022 | 30 | $502.9K |
| Q3 2022 | 28 | $873.0K |
| Q2 2022 | 27 | $1.74M |
| Q1 2022 | 33 | $3.94M |
| Q4 2021 | 28 | $4.75M |
| Q3 2021 | 30 | $12.8M |
| Q2 2021 | 36 | $31.9M |
| Q1 2021 | 45 | $13.7M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Jaguar Health, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CoreCap Advisors, LLC | 1 | $4 | 0.00% | +1 | New |
| International Assets Investment Management, LLC | 2 | $7 | 0.00% | +2 | New |
| Group One Trading, L.P. | 10 | $36 | 0.00% | −727−98.6% | Reduced |
| Bank of America Corp | 40 | $143 | 0.00% | −242,364−100.0% | Reduced |
| BlackRock Inc. | 110 | $394 | 0.00% | −2,595,672−100.0% | Reduced |
| Morgan Stanley | 252 | $902 | 0.00% | −1,427−85.0% | Reduced |
| Tower Research Capital LLC (TRC) | 2,403 | $8.60K | 0.00% | −56,925−95.9% | Reduced |
| Vanguard Group Inc | 10,360 | $37.1K | 0.00% | −181,975−94.6% | Reduced |
| Commonwealth Equity Services, LLC | 10,845 | $39.0K | 0.00% | −888,325−98.8% | Reduced |
| Squarepoint Ops LLC | 22,600 | $80.9K | 0.00% | +22,600 | New |
| Perritt Capital Management Inc | 25,000 | $89.5K | 0.05% | +25,000 | New |
| Geode Capital Management, LLC | 30,835 | $110.4K | 0.00% | −96,836−75.8% | Reduced |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −798,485−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −450,634−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −157,303−100.0% | Sold out |
| Csenge Advisory Group | 0 | $0 | 0.00% | −102,500−100.0% | Sold out |
| Focused Wealth Management, Inc | 0 | $0 | 0.00% | −74,077−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −49,773−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −43,506−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −26,026−100.0% | Sold out |
| ICA Group Wealth Management, LLC | 0 | $0 | 0.00% | −4,500−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −373−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1−100.0% | Sold out |